ARTICLE | Company News
Genentech, Sequitur functional genomics deal
November 21, 2002 8:00 AM UTC
Sequitur (Natick, Mass.) will provide antisense/RNAi compounds and methods to DNA for target validation studies. Sequitur's compounds inhibit gene expression. ...